2000 GALLOPING HILL ROAD, KENILWORTH, NJ
Consolidated Statement of Operations - GAAP
Shareholder Vote Results from Merck & Co., Inc. Annual Meeting
Other Events
Reports First Quarter 2025 Financial Results
Annual Report to Security Holders
Consolidated Statement of Income - GAAP
Q2
Q1
FY 2024
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Tender Offer Statement by Third Party
Definitive Proxy Statement
Additional Proxy Materials
Additional Proxy Soliciting Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Specialized Disclosure Report
Free Writing Prospectus
Amended Tender Offer Statement by Third Party